Topiramate Tablet, Film Coated
Product Images NDC 82009-135

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 82009-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (F79d45f8 Ef87 493f 8301 B3674fab3afd 01)

Chemical structure diagram of the active ingredient topiramate, showing its molecular configuration with carbon, oxygen, sulfur, nitrogen, and hydrogen atoms connected in a specific arrangement.*

FDA Label Image

Structured Product Formula For Topiramate (F79d45f8 Ef87 493f 8301 B3674fab3afd 02)

A line chart comparing cumulative rates for time to first seizure over 500 days for Topiramate at 50 mg/day versus 400 mg/day. The chart shows two lines: a solid line for 50 mg/day and a dashed line for 400 mg/day, with cumulative rates on the y-axis and time in days on the x-axis. Statistical significance (P = 0.0002) is noted.*

FDA Label Image

Topiramate Tablets Usp (F79d45f8 Ef87 493f 8301 B3674fab3afd 03)

Bar chart depicting change from baseline to double-blind phase in average monthly migraine period rate with error bars, comparing placebo and topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day. Data is shown for two studies (Study 11 and Study 12) with sample sizes noted for each group. Statistical significance is indicated by asterisks below bars for topiramate 100 mg/day and 200 mg/day doses.*

FDA Label Image

Topiramate Tablet-sl-25mg-60c (F79d45f8 Ef87 493f 8301 B3674fab3afd 04)

Topiramate Tablets USP 25 mg film-coated oral tablets packaging label by Quallent Pharmaceuticals Health LLC. The label shows a bottle containing 500 tablets with the NDC 82009-135-05. It includes storage instructions, dosage notes, and manufacturer details.*

FDA Label Image

Topiramate Tablet-sl-50mg-60c (F79d45f8 Ef87 493f 8301 B3674fab3afd 05)

Label for Topiramate Tablets USP 50 mg distributed by Quallent Pharmaceuticals Health LLC. The label indicates the package contains 500 film-coated tablets, each containing 50 mg of topiramate. The product is manufactured by Zydus Lifesciences Ltd. in India. Storage instructions, dosage reference, and safety warnings are also included on the label.*

FDA Label Image

Topiramate Tablet-sl-100mg-60c (F79d45f8 Ef87 493f 8301 B3674fab3afd 06)

Label for Topiramate Tablets, USP 100 mg by Quallent Pharmaceuticals Health LLC. The label indicates a package of 500 film-coated tablets, with NDC 82009-137-05. It includes storage instructions, manufacturer information (Zydus Lifesciences Ltd., India), and advises dispensing the Medication Guide to patients. The label features dosage and handling guidance and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.